GrowingStockReport.com

Repligen Corporation (NASDAQ:RGEN), ImmunoGen, Inc. (NASDAQ:IMGN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) Added to Growing Stock Report's NASDAQ Gainers Watch List.

 

New York, NY -- (ReleaseWire) -- 04/10/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Repligen Corporation (NASDAQ:RGEN), ImmunoGen, Inc. (NASDAQ:IMGN), NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), and Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR).

Repligen Corporation (NASDAQ:RGEN) a life sciences company that develops, manufactures, and markets consumable bioprocessing products for life sciences companies and biopharmaceutical manufacturing companies worldwide is currently up (+6.47%) on 781,334 shares traded. Repligen Corporation (NASDAQ:RGEN) is currently up (+150.54%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Repligen Corporation (NASDAQ:RGEN)

ImmunoGen, Inc. (NASDAQ:IMGN) a company that engages in the development of antibody-based anticancer therapeutics is currently up (+5.46%) on 927,650 shares traded after ImmunoGen, Inc. Announced Preclinical Findings with its IMGN289 Product Candidate for the Treatment of EGFR-Overexpressing Cancers. ImmunoGen, Inc. (NASDAQ:IMGN) is currently up (+56.68%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about ImmunoGen, Inc. (NASDAQ:IMGN)

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) a biopharmaceutical company that engages in the development of therapeutic products in the United States is currently up (+7.47%) on 3,166,277 shares traded. NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is currently up (+96.38%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) a company that together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States is currently up (+5.90%) on 890,539 shares traded. Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) is currently up (+37.68%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com